311 related articles for article (PubMed ID: 31243119)
41. Sphingolipid hydrolyzing enzymes in the gastrointestinal tract.
Duan RD; Nilsson A
Methods Enzymol; 2000; 311():276-86. PubMed ID: 10563333
[No Abstract] [Full Text] [Related]
42. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms and regulation of ceramide transport.
Perry RJ; Ridgway ND
Biochim Biophys Acta; 2005 Jun; 1734(3):220-34. PubMed ID: 15907394
[TBL] [Abstract][Full Text] [Related]
44. Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.
Bielawska A; Bielawski J; Szulc ZM; Mayroo N; Liu X; Bai A; Elojeimy S; Rembiesa B; Pierce J; Norris JS; Hannun YA
Bioorg Med Chem; 2008 Jan; 16(2):1032-45. PubMed ID: 17881234
[TBL] [Abstract][Full Text] [Related]
45. Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons.
Nusshold C; Uellen A; Bernhart E; Hammer A; Damm S; Wintersperger A; Reicher H; Hermetter A; Malle E; Sattler W
Biochim Biophys Acta; 2013 Dec; 1831(12):1665-78. PubMed ID: 23973266
[TBL] [Abstract][Full Text] [Related]
46. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
[TBL] [Abstract][Full Text] [Related]
47. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
48. Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides.
Mao C; Xu R; Szulc ZM; Bielawski J; Becker KP; Bielawska A; Galadari SH; Hu W; Obeid LM
J Biol Chem; 2003 Aug; 278(33):31184-91. PubMed ID: 12783875
[TBL] [Abstract][Full Text] [Related]
49. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
[TBL] [Abstract][Full Text] [Related]
50. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
[TBL] [Abstract][Full Text] [Related]
51. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
52. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
53. The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection.
Simonis A; Schubert-Unkmeir A
Biol Chem; 2018 Sep; 399(10):1135-1146. PubMed ID: 29924727
[TBL] [Abstract][Full Text] [Related]
54. Sphingolipids in viral infection.
Schneider-Schaulies J; Schneider-Schaulies S
Biol Chem; 2015 Jun; 396(6-7):585-95. PubMed ID: 25525752
[TBL] [Abstract][Full Text] [Related]
55. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Orešič M; Yki-Järvinen H; Eriksson P; Fisher RM
Lipids Health Dis; 2012 Sep; 11():115. PubMed ID: 22974251
[TBL] [Abstract][Full Text] [Related]
56. Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells.
Funakoshi T; Yasuda S; Fukasawa M; Nishijima M; Hanada K
J Biol Chem; 2000 Sep; 275(39):29938-45. PubMed ID: 10882735
[TBL] [Abstract][Full Text] [Related]
57. Sphingolipid metabolism and its role in the skeletal tissues.
Khavandgar Z; Murshed M
Cell Mol Life Sci; 2015 Mar; 72(5):959-69. PubMed ID: 25424644
[TBL] [Abstract][Full Text] [Related]
58. The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes.
Davis DL; Gable K; Suemitsu J; Dunn TM; Wattenberg BW
J Biol Chem; 2019 Mar; 294(13):5146-5156. PubMed ID: 30700557
[TBL] [Abstract][Full Text] [Related]
59. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
60. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor.
Pagano RE; Martin OC; Kang HC; Haugland RP
J Cell Biol; 1991 Jun; 113(6):1267-79. PubMed ID: 2045412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
